Healthia Valuation

Q: What is the Fair Price of HE3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

HE3 (€0.57) is trading below our estimate of [[fair value]] (€1.06)

Is HE3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HE3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HE3 (€0.57) is trading below our estimate of fair value (€1.06)

Significantly Below Fair Value: HE3 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HE3?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for HE3. This is calculated by dividing HE3's market cap by their current preferred multiple.
What is HE3's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	AU$252.06m

HE3 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.8x
Enterprise Value/EBITDA	13.1x
PEG Ratio	1.1x

Price to Earnings Ratio vs Peers

How does HE3's PE Ratio compare to its peers?

The above table shows the PE ratio for HE3 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	20.5x
SYAB SYNLAB	27.1x	-11.4%	€2.4b
LIK LIMES Schlosskliniken	25.4x	n/a	€108.5m
FME Fresenius Medical Care	21.1x	21.9%	€11.2b
HAEK HAEMATO	8.4x	n/a	€80.5m
HE3 Healthia	46x	40.3%	€252.1m

Price-To-Earnings vs Peers: HE3 is expensive based on its Price-To-Earnings Ratio (46x) compared to the peer average (19x).

Price to Earnings Ratio vs Industry

How does HE3's PE Ratio compare vs other companies in the European Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.6%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.6%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: HE3 is expensive based on its Price-To-Earnings Ratio (46x) compared to the European Healthcare industry average (17.1x).

Price to Earnings Ratio vs Fair Ratio

What is HE3's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HE3 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	46x
Fair PE Ratio	30.7x

Price-To-Earnings vs Fair Ratio: HE3 is expensive based on its Price-To-Earnings Ratio (46x) compared to the estimated Fair Price-To-Earnings Ratio (30.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.